• Tue news: Pfizer explores sale of hospital drugs unit. FDA declines full approval of Ocaliva. AZ better than expected Q3 results. Pfizer, Lilly telehealth platforms draw scrutiny. 23andMe cutting lays off 40%. See more on our front page

FDA Reveals More Details on 22 CAR-T Secondary Cancer Cases

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Jan 25, 2024 at 11:32: AM
via The FDA is currently looking into at least 22 cases of secondary malignancies in patients after receiving CAR-T therapies, according to a perspective piece from two agency officials published Wednesday in The New England Journal of Medicine.

article source
 




Top Bottom
Back
Quote